Demineralized bone matrix in bone repair: History and use

Advanced Drug Delivery Reviews

Volumn 64, Issue 12, 2012, Pages 1063-1077

  Gruskin, Elliott ^a   Doll, Bruce A ^b   Futrell, F William ^b   Schmitz, John P ^b   Hollinger, Jeffrey O ^c  

^a Synthes Technical Center   (United States)

^b Carnegie Mellon University ^*  (United States)

^c CARNEGIE MELLON UNIVERSITY   (United States)

Author keywords

Bone graft; Bone regeneration; DBM; Demineralized bone matrix; Growth factors; Osteoinductive

Indexed keywords

DATABASE SYSTEMS; DEFECTS; REPAIR; TISSUE REGENERATION;

BONE GRAFT; BONE REGENERATION; DEMINERALIZED BONE MATRIX; GROWTH FACTOR; OSTEOINDUCTIVE;

BONE;

BIOMATERIAL;

BIOASSAY; BIOCOMPATIBILITY; BONE DEFECT; BONE DEVELOPMENT; BONE GRAFT; BONE MATRIX; BONE REMODELING; BONE TRANSPLANTATION; COMPOSITE MATERIAL; DENTAL SURGERY; DIMINERALIZED BONE MATRIX; FACE SURGERY; FOOT SURGERY; FRACTURE HEALING; GOVERNMENT REGULATION; GRAFT PRESERVATION; HAND SURGERY; HISTORY OF MEDICINE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INSTRUMENT STERILIZATION; LAW; PRIORITY JOURNAL; REVIEW; SHELF LIFE; SKULL SURGERY; SPINE SURGERY;

EID: 84865306701     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2012.06.008     Document Type: Review

References (119)

1. Group M.R. US Markets for Orthopaedic Bioimaterials 2005, 2004.
2. Groessner-Schreiber B., Krukowski M., Lyons C., Osdoby P. Osteoclast recruitment in response to human bone matrix is age related. Mech. Ageing Dev. 1992, 62:143-154.
3. Aaboe M., Pinholt E.M., Schou S., Hjorting-Hansen E. Incomplete bone regeneration of rabbit calvarial defects using different membranes. Clin. Oral Implants Res. 1998, 9:313-320.
4. Schwartz Z., Somers A., Mellonig J.T., Carnes D., Dean D., Cochran D., Boyan B. Ability of demineralized freeze-dried bone allograft to induce new bone formation is dependent on donor age but not gender. J. Periodontol. 1998, 69:470-478.
5. Zhang M., Powers R.M., Wolfinbarger L. A quantitative assessment of osteoinductivity of human demineralized bone matrix. J. Periodontol. 1997, 68:1076-1084.
6. Harakas N.K. Demineralized bone matrix-induced osteogenesis. Clin. Orthop. Relat. Res. 1984, 188:239-251.
7. Glowacki J., Mulliken J.B. Demineralized bone implants. Clin. Plast. Surg. 1985, 12:233-241.
8. Meek'ren J.J.V. Observationes medico-chirurgicae, Observationes medico-chirurgicae 1632, 6. HT Bloom, Amsterdam.
9. Macewen W. Observations concerning transplantation of bone. Proc. R. Soc. London 1881, 32:232-237.
10. Senn N. On the healing of aseptic cavities by implantation of antiseptic decalcified bone. Am. J. Med. Sci. 1889, 98:219-243.
11. Deaver J.B. Secondary bone implantation by a modification of Senn's method. Med. News 1889, 55:714-721.
12. Curtis B.F. Case of bone implantation and transplantation for cyst of tibia, osteomyelytic cavities and ununited fracture. Am. J. Med. Sci. 1890, 106:30-34.
13. Mackie W. Clinical observations of the healing of aseptic bone cavities by Senn's method of implantation of antiseptic decalcified bone. Med. News 1890, 57:202-210.
14. Phemister D.B. The fate of transplanted bone and regenerative power of its various constituents. Surg. Gynecol. Obstet. 1914, 19:303.
15. Groves E.W. Methods and results of transplantation of bone in the repair of defects. Br. J. Surg. 1917, 5:185.
16. Barth F. Ueber histologische befunde nach knochen-implantation. Arch. Klin. Chir. 1893, 46:409.
17. Axhausen G. Ueber histologische vorgang bei der transplanation von gelenkenden. Arch. Klin. Chir. 1912, 99:1.
18. Urist M.R. Fundamental and Clinical Bone Physiology 1980, J.B. Lippencott, Philadelphia.
19. Huggins C.B. Experimental osteogenesis-influence of urinary tract mucosa on the experimental formation of bone. Proc. Soc. Exp. Biol. Med. 1930, 27:349-353.
20. Huggins C.B. The formation of bone under the influence of epithelium of the urinary tract. Arch. Surg. 1931, 22:377.
21. Neuhof H. Fascia transplantation into visceral defects. Surg. Gynecol. Obstet. 1917, 24:383-427.
22. Urist M.R., Maeda H., Shamie A.N., Teplica D. Endogenous bone morphogenetic protein expression in transplants of urinary bladder. Plast. Reconstr. Surg. 1998, 101:408-415. (discussion 416-407).
23. Levander G. On the formation of new bone in bone transplantation. Acta Chir. Scand. 1934, 74:425-426.
24. Levander G. A study of bone regeneration. Surg. Gynecol. Obstet. 1938, 67:705-714.
25. Lacroix P. Recent investigations on the growth of bone. Nature 1945, 156:576-586.
26. Lacroix P. Organizers and the growth of bone. J. Bone Joint Surg. 1947, 29:292-296.
27. Ray R.D., Holloway J.A. Bone implants. Preliminary report of an experimental study. J. Bone Joint Surg. 1957, 39A:1119.
28. Urist M.R. Bone: formation by autoinduction. Science 1965, 150:893-899.
29. Urist M.R., Strates B.S. Bone morphogenetic protein. J. Dent. Res. 1971, 50:1392-1406.
30. Urist M.R. The substratum for bone morphogenesis. Symp. Soc. Dev. Biol. 1970, 29:125-163.
31. Reddi A.H., Huggins C.B. Influence of geometry of transplanted tooth and bone on transformation of fibroblasts. Proc. Soc. Exp. Biol. Med. 1973, 143:634-637.
32. Reddi A.H., Huggins C.B. Formation of bone marrow in fibroblast-transformation ossicles. Proc. Natl. Acad. Sci. U. S. A. 1975, 72:2212-2216.
33. Reddi A.H., Anderson W.A. Collagenous bone matrix-induced endochondral ossification and hemopoiesis. J. Cell Biol. 1976, 69:557-572.
34. Sampath T.K., Reddi A.H. Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation. Proc. Natl. Acad. Sci. U. S. A. 1981, 78:7599-7603.
35. Muthukumaran N., Ma S., Reddi A.H. Dose-dependence of and threshold for optimal bone induction by collagenous bone matrix and osteogenin-enriched fraction. Coll. Relat. Res. 1988, 8:433-441.
36. Reddi A.H. Morphogenesis and tissue engineering of bone and cartilage: inductive signals, stem cells, and biomimetic biomaterials. Tissue Eng. 2000, 6:351-359.
37. Wozney J.M., Rosen V., Celeste A.J., Mitsock L.M., Whitters M.J., Kriz R.W., Hewick R.M., Wang E.A. Novel regulators of bone formation: molecular clones and activities. Science 1988, 242:1528-1534.
38. Özkaynak E., Rueger D.C., Drier E.A., Corbett C., Ridge R.J., Sampath T.K., Oppermann H. OP-1 cDNA encodes an osteogenic protein in the TGF-ß family. EMBO J. 1990, 9:2085-2093.
39. Chesmel K.D., Branger J., Wertheim H., Scarborough N. Healing response to various forms of human demineralized bone matrix in athymic rat cranial defects. J. Oral Maxillofac. Surg. 1998, 56:857-863. (discussion 864-855).
40. Honsawek S., Powers R.M., Wolfinbarger L. Extractable bone morphogenetic protein and correlation with induced new bone formation in an in vivo assay in the athymic mouse model. Cell Tissue Bank. 2005, 6:13-23.
41. Hollinger J.O., Mark D.E., Goco P., Quigley N., Desverreaux R.W., Bach D.E. A comparison of four particulate bone derivatives. Clin. Orthop. Relat. Res. 1991, 267:255-263.
42. Schouten C.C., Hartman E.H., Spauwen P.H., Jansen J.A. DBM induced ectopic bone formation in the rat: the importance of surface area. J. Mater. Sci. Mater. Med. 2005, 16:149-152.
43. Hunter S.A., Orheim R., Sazon M., Newman H., Woll J.E., Bergevin M. Demineralization removes residual alendronate in allograft bone procured from donors with a history of bisphosphonate use. J. Periodontol. 2011, 82:281-286.
44. Schwartz Z., Hyzy S.L., Moore M.A., Hunter S.A., Ronholdt C.J., Sunwoo M., Boyan B.D. Osteoinductivity of demineralized bone matrix is independent of donor bisphosphonate use. J. Bone Joint Surg. Am. 2011, 93:2278-2286.
45. Wang J.C., Davies M., Kanin L.E. Prospective Comparison of Commercially Available Demineralized Bone Matrix for Spinal Fusion 2000, 35-37. North American Spine Society, New Orleans, LA.
46. Sassard W., Eidman D., Gray P.W. Augmenting local bone with Grafton demineralized bone matrix for posterior lumbar spine fusion: avoiding second site autologous bone harvest. Orthopaedics 2000, 23:1059-1065.
47. Bostrom M., Yang X., Keenan M., Andhu H., Dicarlo E., Lane J. An unexpected outcome during testing of commercially available demineralized bone graft materials: How safe are the nonallograft components. Spine 2001, 26:1425-1428.
48. Safdar N., Khan M., Fraser J.R., Sandhu H., Cammisa F.P., Giradi F., Lane J. Use of osteopromotive growth factors. Spine 2001, 26:1425-1428.
49. O. Acarturk, J.O. Hollinger, Comparison of commercially available particulate demineralized bone products, J. Plastic. Recon., in press.
50. Carpener J., Pikal M., Chang B.H., Randolph T. Rational design of stable lyophilized protein formulations: some practical advice. Pharmacol. Res. 1997, 14:969-975.
51. Scarborough N., White E., Hughes J.L. Autograft safety: Viral inactivation with bone demineralization. Contemp. Orthop. 1995, 31:257-261.
52. Urist M.R., Dowell T.A., Hoy P.H., Strates B.S. Inductive substrates for bone formation. Clin. Orthop. 1968, 59:59.
53. Glowacki J. A review of osteoinductive testing methods and sterilization processes for demineralized bone. Cell Tissue Bank. 2005, 6:3-12.
54. Russell J.L., Block J.E. Clinical utility of demineralized bone matrix for osseous defects, arthrodesis, and reconstruction: impact of processing techniques and study methodology. Orthopedics 1999, 22:524-531. (quiz 532-523).
55. Munting E.V., Wilmart J.-F., Wijen A., Hennebert P.I., Delloye C. Effect of Sterilization on osteoinduction: comparison of five methods in demineralized rat bone. Acta Orthop. Scand. 1988, 59:34-38.
56. Puolakkainen P., Ranchalis J., Strong D., Twardzik D. The effect of sterilization on transforming growth factor beta isolated from demineralized human bone. Transfusion 1993, 33:679-685.
57. Ijiri S., Yamauro T., Nakamura T., Kotani S., Notoya K. Effect of sterilization on bone morphogenetic protein. J. Orthop. Res. 1994, 12:628-636.
58. Urist M.R., Hernandez A. Excitation transter in bone. Deleterious effects of cobalt 60 radiation-sterilization of bank bone. Arch. Surg. 1974, 109:486-493.
59. Glowacki J., Altobeli J., Mulliken J.B. Fate of mineralized and demineralized ossedous implants in cranial defects. Calcif. Tissue Int. 1981, 33:71-76.
60. Wientroub S., Reddi A.H. Influence of irradiation on the osteoinductive potential of demineralized bone matrix. Calcif. Tissue Int. 1988, 42:255-260.
61. Pruss A., Kao M., Gohs U., Koscielny J., von Versen R., Pauli G. The effect of gamma irradiation on human cortical bone transplants contaminated with enveloped and non-enveloped viruses. Biologicals 1993, 30:125-133.
62. Lekishvili M., Snetkov A., Vasiliev M., Il'ina V., Tarasov N., Gorbunova E., Pankratov A., Barakina O., Gavryushenko N., Batrakov S. Experimental and clinical study of the demineralized bone allografts manufactured in the tissue bank of CITO. Cell Tissue Bank. 2004, 5:231-238.
63. Dziedzic-Goclawska A., Kaminski A., Uhrynowska-Tyszkiewicz I., Stachowicz W. Irradiation as a safety procedure in tissue banking. Cell Tissue Bank. 2005, 6:201-219.
64. Ferreira S.D., Dernell W.S., Powers B.E., Schochet R.A., Kuntz C.A., Withrow S.J., Wilkins R.M. Effect of gas-plasma sterilization on the osteoinductive capacity of demineralized bone matrix. Clin. Orthop. Relat. Res. 2001, 233-239.
65. Moore T., Gendler E., Gendler E. Viruses adsorbed on musculoskeletal allografts are inactivated by terminal ethylene oxide disinfectant. J. Orthop. Res. 2004, 22:1358-1361.
66. Aspenberg P., Lohmander L.S., Thorngren K.-G. Monkey bone matrix induces bone formation in the athymic rat, but not in adult monkeys. J. Orthop. Res. 1990, 9:20-25.
67. Doherty M.M., Mollan R., Wilson D. The effect of ethylene oxide sterilization on human demineralized bone. Biomaterials 1993, 14:994-998.
68. Solheim E., Pinholt E.M., Bang G., Sudmann E. Ethylene oxide gas sterilization does not reduce the osteoinductive potential of demineralized bone in rats. J. Craniofac. Surg. 1995, 6:195-198.
69. Zhang M., Powers R.M., Wolfinbarger L. Effect(s) of the demineralization process on the osteoinductivity of demineralized bone matrix. J. Periodontol. 1997, 68:1085-1092.
70. Dupoirieux L., Costes V., Jammet P., Souyris F. Experimental study on demineralized bone matrix (DBM) and coral as bone graft substitutes in maxillofacial surgery. Int. J. Oral Maxillofac. Surg. 1994, 23:395-398.
71. Lomas R.J., Gillan H.L., Matthews J.B., Ingham E., Kearney J.N. An evaluation of the capacity of differently prepared demineralised bone matrices (DBM) and toxic residuals of ethylene oxide (EtOx) to provoke an inflammatory response in vitro. Biomaterials 2001, 22:913-921.
72. Aspenberg P., Lindqvist S.B. Ethene oxide and bone induction. Controversy remains. Acta Orthop. Scand. 1998, 69:173-176.
73. Han B., Yang Z., Nimni M. Effects of moisture and temperature on the osteoinductivity of demineralized bone matrix. J. Orthop. Res. 2005, 23:855-861.
74. Schwartz Z., Mellonig J., Carnes D., Fontaine J., Cochran D., Dean D., Boyan B. Ability of commericial demineralized frezze-dried bone allograft to induce new bone formation. J. Periodontol. 1996, 67:918-926.
75. Takikawa S., Bauer W., Kambic H., Togawa D. Comparative evaluation of the osteoinductivity of two formulations of human demineralized bone matrix. J. Biomed. Mater. Res. 2003, 65:37-42.
76. Oakes D.A., Lee C., Liberman J. An evaluation of human demineralized bone matrices in a rat femoral defect model. Clin. Orthop. Relat. Res. 2003, 413:281-290.
77. Bomback D., Grauer J., Lugo R., Troiano N., Patel T., Friedlaender G. Comparison of posterolateral lumbar fusion rates of Grafton Putty and OP-1 in an athymic rat model. Spine 2004, 29:1612-1617.
78. Peterson B., Whang P., Iglesias R., Wang J., Lieberman J. Osteoinductivity of commercially available demineralized bone matrix: preparation in a spine fusion model. J. Bone Joint Surg. 2004, 86-A:2243-2250.
79. Acarturk O., Hollinger J.O. Comparison of commercially available particulate demineralized bone products. J. Plast. Reconstr. 2006, 118:862-873.
80. Urist M.R. The substratum for bone morphogenesism. Dev. Biol. Suppl. 1970, 4:125-163.
81. Reddi A.H. The matrix of rat calvarium as transformant of fibroblasts (39028). Proc. Soc. Exp. Biol. Med. 1975, 150:324-326.
82. Reddi A.H. Morphogenetic messages are in the extracellular matrix: biotechnology from bench to bedside. Biochem. Soc. Trans. 2000, 28:345-349.
83. Pietrzak W.S., Woodell-May J., McDonald N. Assay of bone morphogenetic protein-2, -4 and -7 in human demineralized bone matrix. J. Craniofac. Surg. 2006, 17:84-90.
84. Honsawek S., Dhitiseith D. Content of bone morphogenetic protein-4 in human demineralized bone: relationship to donor age and ability to induce new bone formation. J. Med. Assoc. Thai. 2005, 88:S260-S265.
85. Blum B., Moseley J., Miller L., Richelsoph K., Haggard W. Measurement of bone morphogenetic proteins and other growth factors in demineralized bone matrix. Orthopedics 2004, 27:s161-s165.
86. Pfeilschifter J., Diel I., Scheppach B., Bretz A., Krempien R., Erdmann J., Schmid G., Reske N., Bismar H., Seck T., Krempien B., Ziegler R. Concentration of transforming growth factor beta in human bone tissue: relationship to age, menopause, bone turnover, and bone volume. J. Bone Miner. Res. 1998, 13:716-730.
87. Bae H., Zhao L., Kanin L., Wong P., Dawson E. Intervariability and intravariability of bone morphogenetic proteins in commercially available demineralized bone matrix products. Spine 2006, 31:1299-1306.
88. Lohmann C.H., Andreacchio D., Koster G., Carnes D.L., Cochran D.L., Dean D.D., Boyan B.D., Schwartz Z. Tissue response and osteoinduction of human bone grafts in vivo. Arch. Orthop. Trauma Surg. 2001, 121:583-590.
89. Traianedes K., Russell J., Edwards J., Stubbs H., Shanahan I., Knaack D. Donor age and gender effects on osteoinductivity of deminralized b one matrix. J. Biomed. Mater. Res. 2004, 70:21-29.
90. Carnes D.J., De La Fontaine J., Cochran D., Mellonig J.T., Keogh B., Harris S.E., Ghosh-Choudhury N., Dean D.D., Boyan B.D., Schwartz Z. DFDBA donor age effects in vitro and in vivo. J. Periodontal 1999, 70.
91. Adkisson H.A., Straus-Schoenberger J., Gillis M., Wilkins R., Jackson M.T., Hrushka K.A. Rapid quantitative bioassay for osteoinduction. J. Orthop. Res. 2005, 18:503-511.
92. Burwell R.G. Studies in the transplantation of bone. VII. The fresh composite homograft-autografts of cancellous bone: an analysis of inductive mechanisms in bone transplantation. J. Bone Joint Surg. 1964, 46-B:110-140.
93. Pike R.L., Boyne P.J. Composite autogenous marrow and surface-decalcified implants in mandibular defects. J. Oral Surg. 1973, 31:905-912.
94. Lindholm T.S., Urist M.R. A quantitative analysis of new bone formation by induction in compositive grafts of bone marrow and bone matrix. Clin. Orthop. 1980, 150:288-300.
95. Lindholm T.S., Nilsson O.S., Lindholm T.C. Extraskeletal and intraskeletal new bone formation induced by demineralized bone matrix combined with bone marrow cells. Clin. Orthop. 1982, 171:251-255.
96. Pearson G.E., Rosen S., Deporter D.A. Preliminary observations on the usefulness of a decalcified, freeze-dried cancellous bone allograft material in periodontal surgery. J. Periodontol. 1981, 52:55-59.
97. Sonis S.T., Kaban L.B., Glowacki J. Clinical trial of demineralized bone powder in the treatment of periodontal defects. J. Oral Med. 1983, 38:117-122.
98. Bowers G.M., Chadroff M., Carnevale R., Mellonig J., Corio R., Emerson J., Stevens M., Romberg E. Histologic evaluation of new attachment apparatus formation in humans. Part III. J. Periodontol. 1989, 60:683-693.
99. Bowers G.M., Chadroff M., Carnevale R., Mellonig J., Corio R., Emerson J., Stevens M., Romberg E. Histologic evaluation of new attachment apparatus formation in humans. Part II. J. Periodontol. 1989, 60:675-682.
100. Nevins M.L., Camelo M., Nevins M., King C.J., Oringer R.J., Schenk R.K., Fiorellini J.P. Human histologic evaluation of bioactive ceramic in the treatment of periodontal osseous defects. Int. J. Periodontics Restorative Dent. 2000, 20:458-467.
101. Nevins M., Camelo M., Nevins M.L., Schenck R., Lynch S. Periodontal regeneration in humans using recombinant human platelet-derived growth factor BB (rhPDGF-BB) and allogeneic bone. J. Periodontol. 2003, 74:1282-1292.
102. Nevins M., Giannobile W.V., McGuire M.H., Kao R., Mellonig J., Hinrichs J., McAllister B., Murphy K.G., McClain P., Nevins M.L., Paquette D.W., Han T., Reddy M., Lavin P.T., Genco R., Lynch S. Platelet-derived growth factor stimulates bone fill and rate of attachment level gain: results of a large multicenter randomized controlled trial. J. Periodontol. 2005, 76:2205-2215.
103. Mulliken J.B., Glowacki J., Kaban L.B., Folkman J., Murray J.E. Use of demineralized allogenic bone implants for the correction of maxillocraniofacial deformities. Ann. Surg. 1981, 194:366-372.
104. Habal M.B. Reconstruction of a large congenital cranioorbital defect with a species-specific demineralized bone implant. J. Craniofac. Surg. 1992, 3:113-118.
105. Salyer K.E., Gendler E., Menendez J.L., Simon T.R., Kelly K.M., Bardach J. Demineralized perforated bone implants in craniofacial surgery. J. Craniofac. Surg. 1992, 3:55-62.
106. Ousterhout D.K. Clinical experience in cranial and facial reconstruction using demineralized bone. Ann. Plast. Surg. 1985, 15:367-373.
107. Upton J., Glowacki J. Hand reconstruction with allograft demineralized bone: twenty-six implants in twelve patients. J. Hand Surg. 1992, 17:704-713.
108. Whiteman D., Gropper P.T., Wirtz P., Monk P. Demineralized bone powder. Clinical applications for bone defects of the hand. J. Hand Surg. Br 1993, 18:487-490.
109. Kado K.E., Gambetta L.A., Perlman M.D. Uses of Grafton for reconstructive foot and ankle surgery. J. Foot Ankle Surg. 1996, 35:59-66.
110. Weinraub G.M., Cheung C. Efficacy of allogenic bone implants in a series of consecutive elective foot procedures. J. Foot Ankle Surg. 2003, 42:86-89.
111. Michelson J.J., Curl L.A. Use of demineralized bone in hindfoot arthrodesis. Clin. Orthop. 1996, 325:203-208.
112. Killian J.T., Wilkinson L., White S., Brassard M. Treatment of unicameral bone cyst with demineralized bone matrix. J. Pediatr. Orthop. 1998, 18:621-624.
113. Tiedman J.J., Garvin K.L., Kile T.A., Connolly J.F. The role of composite, demineralized bone marrow in the treatment of osseous defects. Orthopaedics 1995, 18:1153-1158.
114. Geesink R.G., Hoefnagels N.H., Bulstra S.K. Osteogenic activity of OP-1 bone morphogenetic protein (BMP-7) in a human fibular defect. J. Bone Joint Surg. Br. 1999, 81:710-718.
115. Ladd A.L., Pliam N.B. Use of bone-graft substitutes in distal radius fractures. J. Am. Acad. Orthop. Surg. 1999, 7:279-290.
116. Sassard W.R., Eidman D.K., Gray P.M., Block J.E., Russo R., Russell J.L., Taboada E.M. Augmenting local bone with Grafton demineralized bone matrix for posterolateral lumbar spine fusion: avoiding second site autologous bone harvest. Orthopaedics 2000, 23:1059-1064.
117. Cammisa F.P., Lowery G.L., Geisler F.H., McGuire R., Stubbs H., Block J.A. Two year fusion rate equivalency between Grafton DBM gel and autograft in posterolateral spine fusion: a prospective controlled trial employing a side-by-side comparison in the same patient. Spine 2004, 29:660-666.
118. An H.S., Simpson J.M., Glover J.M., Stephany J. Abstract, S.O. 15;20(20):2211-6., Comparison between allograft plus demineralized bone matrix versus autograft in anterior cervical fusion. A prospective multicenter study. Spine 1995, 20:2211-2216.
119. Lee K., Roper J., Wang J. Demineralized bone matrix and spine arthrodesis. Spine 2005, 5:217S-223S.